Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Zimmer Biomet selects as Indo UK Institutes of Health Medicities Program’s preferred orthopaedic partner to improve delivery of care in India

Zimmer Biomet Holdings announced that the company has been chosen as an Indo UK Institutes of Health (IUIH) preferred orthopaedic partner to improve the delivery of and access to quality, affordable musculoskeletal healthcare for approximately 400 million people in India over the next 20 years through IUIH's 11 centers of excellence ("Medicities") to be created in major states across the country.

IUIH Medicities will offer patients throughout India and abroad access to world-class services and clinical expertise in a modern, technology-led hospital.  In addition, each Medicity will establish a medical college, nursing college, post-graduate training center, global standard research and development center and medical manufacturing facilities.  

The partnership was announced by the IUIH Medicities Program at the India-UK Technology Summit inaugurated by the Prime Minister of India, Narendra Modi, and the Prime Minister of the UK, Theresa May.  The UK Secretary of State for International Trade, Dr. Liam Fox, chaired the roundtable that announced the partnership.

"At its one-year anniversary, the IUIH Medicities Program is delighted to announce Zimmer Biomet as a preferred orthopaedic partner for the next two decades," said Ajay Rajan Gupta, M.D., Group Chief Executive Officer of IUIH.  

"IUIH shares Zimmer Biomet's commitment to improve the quality of life for patients around the world.  This partnership demonstrates a significant step toward achieving our vision to transform the delivery of quality healthcare and medical education services across India."

The newly created partnership between IUIH and Zimmer Biomet delivers value throughout the orthopaedic care continuum.  

Total Zimmer Biomet commitments to the program include an equity investment in UK Global Healthcare Limited (UKGH), the parent organization for IUIH; the supply and distribution of quality large joint implants, trauma products and small fixation devices for replacement surgery.

The implementation of the Rapid Recovery and Theatre Care Rapide programs to optimize patient-focused processes and protocols in the hospitals and operating rooms across the 11 Medicities; and the establishment of the Zimmer Biomet Institute of India, a state-of-the-art medical training and education facility.  

In addition to the opportunity to improve patient outcomes, the efficiencies created through the long-term partnership are expected to significantly contribute to the delivery of affordable care in India by reducing the total cost of orthopaedic care by approximately 25 percent.

"Zimmer Biomet is proud to be chosen as a preferred orthopaedic partner for the IUIH Medicities program," said David Dvorak, President and CEO of Zimmer Biomet.  "This long-term commitment demonstrates an unprecedented level of partnership between a forward-looking healthcare provider and a leading musculoskeletal healthcare company, putting transformational patient care and exponential value creation within reach."

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare.

We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.